• Best mulig behandling med antiepileptika for den enkelte pasient! 

      Landmark, Cecilie Johannessen; Baftiu, Arton; Burns, Margrete Larsen; Mevåg, Morten A; Feet, Silje Andrea; Reiter, Lillian; Johannessen, Svein Ivar (Norsk Farmaceutisk Tidsskrift;(2), Journal article; Peer reviewed, 2015)
      Hensikt «Best mulig behandling med antiepileptika for den enkelte pasient!» er et avgjørende mål for behandling av pasienter med epilepsi, men også for stadig nye pasientgrupper som bruker antiepileptika. Hensikten med ...
    • Changes in the use of antiseizure medications in children and adolescents in Norway, 2009–2018 

      Heger, Katrine; Skipsfjord, Julia; Kiselev, Yury; Burns, Margrete Larsen; Aaberg, Kari Modalsli; Johannessen, Svein Ivar; Skurtveit, Svetlana Ondrasova; Landmark, Cecilie Johannessen (Epilepsy Research;Volume 181, March 2022, 106872, Peer reviewed; Journal article, 2022-02-15)
      Background: The use of antiseizure medications (ASMs) in the pediatric population is poorly studied. The purpose of this study was to investigate changes in the use of ASMs in children and adolescents compared to adults, ...
    • Pharmacokinetic variability and clinical use of lacosamide in children and adolescents in Denmark and Norway 

      Burns, Margrete Larsen; Nikanorova, Marina; Baftiu, Arton; Rasmussen, Jan Borg; Johannessen, Svein Ivar; Landmark, Cecilie Johannessen (Therapeutic Drug Monitoring;41 (3): 340–347, JUNE 2019, Journal article; Peer reviewed, 2019-01-01)
      Background: The indication for the antiepileptic drug (AED) lacosamide (LCM) was recently extended to include children from the age of four. Real-life data on the use and serum concentrations of LCM in children and ...
    • Reference ranges for antiepileptic drugs revisited: a practical approach to establish national guidelines 

      Reimers, Arne; Berg, Jon Andsnes; Burns, Margrete Larsen; Brodtkorb, Eylert; Johannessen, Svein Ivar; Landmark, Cecilie Johannessen (Journal article; Peer reviewed, 2018)
      Background and objective: Laboratories sometimes use different reference ranges for the same antiepileptic drug (AED), particularly for new and poorly investigated drugs. This may contribute to misunderstandings, concerns ...
    • A retrospective review of changes and challenges in the use ofantiseizure medicines in Dravet syndrome in Norway 

      Lund, Caroline; Burns, Margrete Larsen; Bjørnvold, Marit; Sætre, Erik; Johannessen, Svein Ivar; Landmark, Cecilie Johannessen; Heger, Katrine (Epilepsia Open;Volume 5, Issue 3, September 2020, Journal article; Peer reviewed, 2020-06-26)
      Objective: Dravet syndrome is a developmental and epileptic encephalopathy characterized by severe and drug-resistant seizures in early childhood, followed by developmental delay. The purpose of this study was to investigate ...